Skepticism Mounts On Volatile Valeant Pharmaceuticals Intl Inc (VRX)

Short interest has surged on target Valeant Pharmaceuticals Intl Inc (NYSE:VRX)

Apr 12, 2016 at 3:35 PM
facebook twitter linkedin


Short sellers continue to target Valeant Pharmaceuticals Intl Inc (NYSE:VRX), even though the biotech stock has already dropped 88% since its all-time high of $263.81 in August. In the latest two-week reporting period alone, short interest on VRX increased by 56.1% to 18 million shares -- the most since early August. However, there's still plenty of room on VRX's bearish bandwagon, considering it would take short sellers less than one day to cover their positions, at the average daily pace of trading. 

Meanwhile, it looks as if options traders have been betting on a rebound. VRX's 10-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) comes in at 2.26 -- in the 83rd percentile of its annual range. In short, call buying has been extremely popular lately. Given the massive increase in short selling, though, some of this could be indicative of shorts hedging their bearish bets.

Elsewhere, while the majority of analysts are skeptical of the stock, there's still a handful of holdouts. Specifically, five brokerage firms still say VRX is a "strong buy," while the average 12-month price target of $63.67 is roughly double the equity's current perch. This morning, though, RBC lowered its price target on VRX to $65 from $69. 

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has found no shortage of ways to make headlines in recent months, as the shares have plummeted. Today, however, VRX has managed a 2.4% gain at $32.09, in light of news that the company has received an extension for filing its annual report. VRX now has until May 31 to release its financial statement. 
 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

 


 


 
Special Offers from Schaeffer's Trading Partners